TEMAS

- Diagnóstico temprano de la enfermedad de Alzheimer para ayudar a ensayos clínicos
- Conocer empresas y formarse en emprendimiento empresarial
- Asumir riesgos en proyectos de investigación
- Metilación del ADN mitocondrial
- Científicos haciendo un MBA
- La importancia del equipo en la investigación científica.
- Estudiar lo que apasiona, no lo que tiene más “salida”
- La compañía como ingrediente esencial en los viajes


NOTAS:
- Cayo Levisa: https://www.visitarcuba.org/cayo-levisa-pinar-del-rio

- Valle de Viñales: https://queverenelmundo.com/que-ver-en-cuba/parque-nacional-valle-de-vinales/

- Discurso de Sydney Brenner en la UPF (2014): https://www.upf.edu/web/universitat/sydney-brenner
-
- https://www.admit-therapeutics.com/en/team.html


LOCALIZACIÓN: Instituto de Investigaciones Biomédicas de Bellvitge (IDIBELL)


SOBRE MARTA BARRACHINA:

PhD in Biochemistry (University of Barcelona) and Executive MBA (La Salle – Ramon Llull University).

Specialist in gene regulation and epigenetics in neurodegenerative and neurological diseases such as Alzheimer’s disease, Parkinson’s disease, Huntington’s disease and Schizophrenia. Author of 38 scientific articles published in international journals related to neurosciences, h index equal to 22, and inventor of 9 patents. Miguel Servet researcher (Institute of Health Carlos III - ISCIII) in 2008, she holds a permanent position in IDIBELL as principal investigator. She has leaded several national and private competitive projects in the last 16 years (Institute of Neuropathology – Bellvitge Hospital – IDIBELL). She has directed three doctoral thesis and five experimental masters. Member of the Scientific Review Board at the Alzheimer's Drug Discovery Foundation.